期刊文献+

药物保守治疗未破裂型输卵管妊娠的临床评价 被引量:1

下载PDF
导出
摘要 目的探讨药物保守治疗未破裂型输卯管妊娠的临床疗效和安全性。方法将80例未破裂型输卯管妊娠患者随机分成观察组和对照组,各40例,观察组应用甲氨喋呤联合四氢叶酸钙,对照组应用大剂量米非司酮,观察两组患者的临床疗效、血B—HCG下降情况、腹痛消失时问及药物副反应。结果观察组治疗效果好于对照组(P〈0.05),如治愈率高于对照组、腹痛消失时间短于对照组。结论甲氨喋呤联合四氢叶酸钙保守治疗未破裂型输卯管妊娠的临床效果好、副反应小,有利于患者的身体健康。 Objective To explore the clinical effect and safety of drugs conservatively treating un - cracked oviduct pregnancy conservatively, and to find more appropriate drugs. Methods 80 patients with un - cracked oviduct pregnancy were randomly divided into the intervention group(40 cases) and control group (40 cases). The intervention group were treated with methotrexate combined calcium folinate, the control group were treated with high dose mifepristone. To observe the clinical efficacy of two groups, the decline of the blood [3 - HCG,pain disappeared time and adverse drug reactions. Results To compare two sets of data, such as the total cure rate,pain disappeared time, et al, significant difference ( P 〈 0. 05 ). Conclusion The methotrexate combined with calcium folinate conservatively treating un - cracked oviduct pregnancy has good clinical efficacy, fewer adverse drug reactions, and hence is woithy of being recommended in clinical practice.
作者 姚春英 王利
出处 《浙江临床医学》 2011年第2期143-145,共3页 Zhejiang Clinical Medical Journal
关键词 未破裂型输卵管妊娠 四氢叶酸钙 米非司酮 甲氨喋呤 保守治疗 Un -cracked oviduct pregnancy Methotrexate Calcium folinate Mifepristone Conservatively treating
  • 相关文献

参考文献8

二级参考文献46

  • 1Vassilidon N, Balmer J. Characterization of tubal and decidual leukocyte populations in ectopic pregnancy: evidance that endometrial granulated lymphocytes are absent from the tubal implantation site.Fertil Steril, 1998,69 (4) :760.
  • 2Creinin MD, Drohn MA. Metrotrexate pharmacokinetics and effects in women receiving metrotrexate 50mg and 60mg per square meter for early abortion. Am J Obstet Gynecol,1997,177(6) :1444.
  • 3Isaacs JD, Mcgehee RP, Cowan BD. Life threatening neutropenia following methotrexate treatment of ectopic pregnancy: a report of two cases. Obstet Gynecol, 1996,88 (4Pt2) :694.
  • 4Horrigan TJ, Fanning J, Marcotte MP. Methotrexate pneumonitis after systemic treatment for ectopic pregnancy. Am J Obstet Gyncol,1997,176(3) :714.
  • 5Ben-Shlomo I, Eliyahu S, Yanai N, et al. Methotrexate as a possible cause of ovarian cysts formation: experience with women treated for ectopic pregnancies. Fertil Steri], 1997,67 (4) :786.
  • 6Perdu M, Camus E, Rozenberg P, et al. Treating ectopic pregnancy with the combination of mifepristone and methotrexate: a phase Ⅱ non - randomized study. Am J Obstet Gynecol, 1998,179 ( 3 Pt 1 ) :640.
  • 7Zhang W,Wang L. Mifepfistone in treating ectopic pregnancy. Chin Med J (Engl) ,1999,112(4) :376.
  • 8Korhonen J ,Stennan VH, Ylostalo P. Serum human chorionic gonadotropin dynamics during spontaneous resolution of ectopic Pregnancy. Fertil Steril,1994,61 (4) :632.
  • 9Anne E, Damien S, Michel C, et al. Survival analysis of fertility after ectopic pregnancy. Fertil Steril,2001,75 (3) :560.
  • 10Bouyer J, Job SN, Pouly JI, et al. Fertility after ectopic pregnancy:first results of population-based cohort study in France. Br J Obstet Gynecol,2000,107 (6) :714.

共引文献698

同被引文献5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部